3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 1
1
Status
Recruiting
2
Terminated
1
Sponsor Class
OTHER
2
OTHER_GOV
1
Study Type
Observational
11
Interventional
3
Sponsor
Cancer Type
Tumor-Agnostic
1
Gastrointestinal
1
CNS
1
Conditions
Lung Neoplasms
8
Colorectal Neoplasms
4
Stomach Neoplasms
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Neoplasms
3
Smoking Cessation
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Motor Activity
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Colonic Neoplasms
2
Wilms Tumor
1
Venous Thromboembolism
1
Uveal Melanoma
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Recurrence
1
Pulmonary Disease, Chronic Obstructive
1
Opioid-Related Disorders
1
Neuroblastoma
1
Neoplastic Cells, Circulating
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Inflammation
1
Hodgkin Disease
1
Hepatic Veno-Occlusive Disease
1
HPV Positive Oropharyngeal Squamous Cell Carcinoma
1
Fibrosis
1
Interventions
pembrolizumab
180
Gemcitabine
168
Paclitaxel
150
Carboplatin
134
Bevacizumab
126
Cisplatin
113
Docetaxel
112
Cyclophosphamide
109
Exercise
97
Nivolumab
92
Fluorouracil
88
Capecitabine
85
Dexamethasone
81
Irinotecan
74
Radiotherapy
68
Oxaliplatin
68
Pemetrexed
66
Standard of Care
64
Leucovorin
63
Cetuximab
59
Sorafenib
53
Erlotinib Hydrochloride
53
Drug Therapy
53
Blood Specimen Collection
52
Doxorubicin
50
trametinib
47
atezolizumab
47
Ipilimumab
47
Albumin-Bound Paclitaxel
44
130-nm albumin-bound paclitaxel
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Interventional
×
Neoplasms
×
Hematologic Tests
×
Clear all
NCT06999785
2026-04-06
OXYBAR
University Hospital, Angers
Phase NA
Recruiting
60 enrolled
NCT02780128
2026-03-10
NEPENTHE
Children's Hospital of Philadelphia
Phase 1
Terminated
66 enrolled
NCT06346054
2026-02-17
MAGEC
KU Leuven
Phase NA
Recruiting
1,000 enrolled